Taking a proportionate approach to technology appraisals

12 September 2023 - In 2022, NICE introduced the first phase of a new proportionate approach to technology appraisals. ...

Read more →

Global expert panel publishes guidance on deliberative processes for health technology assessment

7 June 2022 - Value in Health announced today the publication of guidance regarding the establishment or improvement of deliberative ...

Read more →

NICE’s health technology assessment methods and processes to be evaluated

19 August 2021 - NICE has launched a public consultation on proposed changes to the way it develops recommendations across ...

Read more →

NICE methods and process review aims to create fertile ground for innovation

29 March 2021 - The way NICE reviews new medicines is about to go through its biggest change in years – ...

Read more →

NICE collaboration on streamlined licensing and patient access process for new medicines opened on January 1st

4 January 2020 - Companies can now submit medicines for the new Innovative Licensing and Access Pathway following close collaboration between ...

Read more →

NICE proposes simplifying how medicines and medical devices are selected for evaluation

12 October 2020 - As part of the work underway to review the methods and processes NICE uses to develop guidance ...

Read more →

After 20 years of using economic evaluation, should NICE be considered a methods innovator?

13 January 2020 - NICE is only one of several organisations internationally that uses economic evaluation as part of decision ...

Read more →

NICE announces details of health technology evaluation methods review

22 July 2019 - Following approval at its recent Board meeting NICE has confirmed the details of its review of the ...

Read more →

NHS England in legal battle with American firm over medicine procurement

7 November 2018 - An American pharmaceutical company has launched a legal challenge against NHS England over a procurement process ...

Read more →

Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

23 January 2018 - Although health technology assessment systems base their decision making process either on economic evaluations or comparative clinical ...

Read more →

Comprehensive assessment of complex technologies: integrating various aspects in health technology assessment

7 August 2017 - Despite recent development of health technology assessment (HTA) methods, there are still methodological gaps for the assessment ...

Read more →

Managing conflicts of interest – making good decisions

24 July 2017 - NICE is seeking views on a new conflicts of interest policy to ensure its committees’ decisions ...

Read more →

HTA programme response to the challenges of dealing with orphan medicinal products: process evaluation in selected European countries

15 May 2017 - Challenges commonly encountered in HTA of orphan medicinal products (OMPs) were identified in Advance-HTA. Since then, new ...

Read more →

Medicines evaluation not keeping pace with scientific progress, says ABPI

3 February 2017 - Following the news that a new breast cancer medicine - palbociclib - from Pfizer has been ...

Read more →

Deal or delay: NICE's new negotiating chip

20 October 2016 - With the UK's NHS facing a financial challenge that shows no signs of abating any time ...

Read more →